Skip to content

Extracorporeal Shock-wave Therapy for Supraspinatus Calcifying Tendonitis: a Randomized Clinical Trial Comparing Two Different Energy Levels

Extracorporeal Shock-wave Therapy for Supraspinatus Calcifying Tendonitis: a Randomized Clinical Trial Comparing Two Different Energy Levels

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01602653
Enrollment
46
Registered
2012-05-21
Start date
2008-11-30
Completion date
2010-06-30
Last updated
2012-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supraspinatus Calcifying Tendonitis

Brief summary

The purpose of this study is to compare two different ranges of energy flux density with Extracorporeal Shock Wave Therapy in treatment of supraspinatus calcifying tendonitis.

Interventions

an energy level of 0.20mJ/mm2, 2400 pulses once a week for 4 weeks.

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* no visible clinical benefits by previous conservative treatment * medium and large calcific deposits, according to Bosworth classification * type I and II Gartner deposits

Exclusion criteria

* presence of tiny calcific deposits, according to Bosworth classification * type III, according to the Gartner classification * age (if less than 18 years old), diabetes, coagulation diseases or anticoagulant therapy, tumors, bone infections, previous shoulder surgery, pregnancy, pace-maker, acute bursitis demonstrated by ultrasound imaging, rheumatoid arthritis or other connective tissue diseases

Design outcomes

Primary

MeasureTime frameDescription
Constant Murley ScaleChange in the mean Constant Murley Scale (CMS) scores at 3 and 6 months was the primary endpoint.Constant-Murley scale is the scoring system used to assess shoulder function in four of the studies being reviewed. It combines physical examination tests with subjective evaluations by the patients and consists of 35 points and 65 points respectively. Its strength is the method of its application, which is quite clearly described, and its being an improvement on pre-existing scales

Secondary

MeasureTime frameDescription
Visual Analogic ScaleThe change in the mean Visual Analogic Scale scores from baseline to 3 and 6 months after the interventionIt is a horizontal line, 10 cm in length with 0 cm labeled no pain and 10 cm labeled worst pain I have ever had. The patient marks on the line the point that they feel represents their perception of their current state

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026